Hpv-related Oropharyngeal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Hpv-related Oropharyngeal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) [Phase 2]
Phase 2 clinical trial evaluating whether cell-free tumor DNA testing can guide the timing of initiating routine treatment for HPV-associate…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma [NA]
This clinical trial update describes using pre-operative MRI to assess margin status during transoral robotic surgery for HPV-positive tonsi…
-
CLINICAL_TRIALS withdrawal · 2024-07-31Clinical Trial Update: PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing [Phase 2]
The PROGRESS trial evaluating prophylactic gabapentin to relieve symptoms and improve swallowing in oropharyngeal cancer (HPV-related oropha…
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)" [Phase 2]
Phase 2 results from the Minimalist Trial (MINT) evaluating surgery followed by risk-directed postoperative adjuvant therapy for HPV-related…